scispace - formally typeset
F

Feizollah Mansouri

Researcher at Kermanshah University of Medical Sciences

Publications -  48
Citations -  264

Feizollah Mansouri is an academic researcher from Kermanshah University of Medical Sciences. The author has contributed to research in topics: Vaccination & Hepatitis B. The author has an hindex of 7, co-authored 43 publications receiving 188 citations.

Papers
More filters
Journal Article

The First Epidemic and New-emerging Human Fascioliasis in Kermanshah (Western Iran) and a Ten-year Follow Up, 1998-2008

TL;DR: It was the first case of human fascioliasis in west Iran and was a real epidemic and an emerging infectious disease for this area at that time and the clinical symptoms were less severe compared with other reports.
Journal Article

Seroepidemiology of Hepatitis C in Kermanshah (West of Iran, 2006)

TL;DR: It is estimated that among 967196 people, who live in Kermanshah, nearly 8400 individuals may have HCV infection and this will be a major problem in the near future.
Journal Article

Hepatitis d virus infection among hiv-hbv co-infected patients in kermanshah, west of iran

TL;DR: The prevalence rate for HIV and co-infection with hepatitis D virus found in this study was much lower than those reported elsewhere and is probably associated with the local epidemiology of these viruses and the degree of overlap of their shared risk factors.
Journal ArticleDOI

Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.

TL;DR: In this paper, a focused review provides the latest recommendations and considerations for these special populations (i.e., patients with rheumatologic and autoimmune disorders, cancer, transplant recipients, chronic liver diseases, end-stage renal disease, neurologic disorders, psychiatric disorders, diabetes mellitus, obesity, cardiovascular diseases, chronic obstructive pulmonary disease, human immunodeficiency virus, current smokers, pregnant and breastfeeding women, the elderly, children, and patients with allergic reactions) using the currently available research evidence.